Breast cancer: percentage of patients for whom combination chemotherapy is considered or administered within 4 months (120 days) of diagnosis for women under 70 with AJCC T1c, or stage II or III hormone receptor negative breast cancer.

TITLE
Breast cancer: percentage of patients for whom combination chemotherapy is considered or administered within 4 months (120 days) of diagnosis for women under 70 with AJCC T1c, or stage II or III hormone receptor negative breast cancer.

SOURCE(S)
ASCO/NCCN quality measures: breast and colorectal cancers. Alexandria (VA): American Society of Clinical Oncology, National Comprehensive Cancer Network, Inc.; 2007 Apr. 5 p.

abrir aquí para acceder al documento completo:
Breast cancer: percentage of patients for whom combination chemotherapy is considered or administered within 4 months (120 days) of diagnosis for women under 70 with AJCC T1c, or stage II or III hormone receptor negative breast cancer.